瘤性聚合物介导的combretastatin A4酸盐供应用于增强血管破坏性治疗
Huihui Li1, Kang Liu1, Zexin Yang1
1School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China.
International journal of pharmaceutics
|March 9, 2025
概括
这项研究介绍了OPAA@CA4P纳米颗粒,这是一种新的组合疗法,有效地针对瘤核心和外围. 这种方法克服了缺氧环境中血管破坏剂 (VDA) 的局限性,显著改善了癌症治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 血管破坏剂 (VDAs) 有效诱导瘤核心亡,但与外围瘤细胞作斗争.
- 血管干扰后瘤微环境中的缺氧限制了传统的组合疗法.
- 需要新的策略,通过向剩余的瘤细胞来增强VDA的疗效.
研究的目的:
- 开发一种新的纳米粒子系统,用于联合VDA和聚合物递送.
- 为了克服缺氧在增强癌症治疗中的局限性.
- 提高VDAs对固体瘤的整体治疗疗效.
主要方法:
- 开发一种由e-polylysine衍生而来的解聚合物 (OPAA),具有膜解活性,在低毒条件下有效.
- 响应pH的纳米颗粒 (OPAA@CA4PNP) 的设计,可同时提供OPAA和酸酸盐 (CA4P).
- 与现有治疗方法相比,血清半衰期,瘤积累和体内治疗疗效的评估.
主要成果:
- 在低毒性条件下,OPAA表现出强烈的细胞毒性 (IC50比为0.98).
- OPAA@CA4PNP显示了延长的血清半衰期 (3.15小时与CA4P的0.31小时相比) 和增强的瘤积累.
- 与CA4P + doxorubicin (36.17%) 相比,OPAA@CA4P NP实现了更高的瘤抑制率 (60.30%) 和CA4P + doxorubicin (36.17%) 相比.
结论:
- 开发的OPAA@CA4PNP有效地提供了解聚合物和VDA.
- 这种组合策略克服了缺氧诱导的限制,并针对中央和外围瘤细胞.
- 瘤解剖聚合物代表了一种有前途的方法,以提高VDA在癌症治疗中的临床应用.
更多相关视频
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.4K
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
相关概念视频
01:27Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K